Research confirms that physical fitness peaks at 35, but there's encouraging news about what you can do to slow the inevitable decline.

Phase 2a trial of atebimetinib + mGnP in first-line pancreatic cancer patients, well above the standard of care benchmark from GnP of 35% overall survival; On track for expanded pancreatic cancer ...